Richard /ca/ Murray, CEO and President at Jounce Therapeutics, Inc. (JNCE), sold 7,150 shares at $7.78 ($56K) on 2020-01-07, disclosed to the SEC on 2020-01-10.
Open-market sale of $56k JNCE by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JNCE | SELL | 2022-01-11 | $416K | — | Filing → |
| JNCE | SELL | 2021-01-25 | $808K | — | Filing → |
| JNCE | SELL | 2021-01-20 | $1.3M | — | Filing → |